Pharma and BioTech Daily
Pharma & Biotech Daily is a short, AI-generated, human-supervised briefing on what’s important in pharma and biotech.
Each weekday we condense key news on pipelines, deals, regulation and strategy into a quick audio update for people who build, run and invest in life sciences.
Produced by OWITH.ai, a boutique AI & data studio.
Sponsor the show: https://sponsor.owith.ai
Pharma and BioTech Daily
Week in Review November 1st
Use Left/Right to seek, Home/End to jump to start or end. Hold shift to jump forward or backward.
This Week in Review covers 5 episodes from October 27 to October 31, featuring major developments in the pharmaceutical and biotech industries.
Episodes included:
1. Pharma Shifts: Dual-Action Obesity Drugs & Regulatory Waves
2. Navigating Pharma's New Frontiers: Breakthroughs and Challenges
3. Gene Therapy Challenges and Regulatory Shifts: Industry Innovations
4. Biotech Breakthroughs: Transformative Acquisitions and FDA Milestones
5. Novartis' $12B RNA Therapeutics Breakthrough
Key topics covered:-
Strategic acquisitions and partnerships
- Regulatory updates and FDA approvals
- Clinical trial results and breakthroughs
- Industry trends and market developments
Stay informed with Pharma Daily's comprehensive coverage of the pharmaceutical and biotech world.